Authors such as Gulbinas A et al., 2006, and Engelsen I et al., 2008, found that increased expression of GATA3 in malignancies of the pancreas, endometrial carcinoma, and others negatively impact the degree of differentiation tumor stage and patient prognosis [20,21]. This evidence concerns the gene GATA3 and neoplasm.